GlassScriptPhysician profile
Mariano E Rivera
NPI 1528389939
$1,925.55
in general payments reported to CMS, 2019-2025
32 companies · $281 in 2025
The $281 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $75.43 · 2021: $102 · 2022: $179 · 2023: $734 · 2024: $390 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,405.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $277.78 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $262.13 | 2019-2024 | Collagenase Santyl, Renasys Touch, Renasys Go V2 Home |
| Organogenesis INC. | $210.63 | 2020-2025 | Puraply Wound Matrix, Puraply, Affinity |
| Solventum Corporation | $139.63 | 2024-2025 | Activ.A.C., V.A.C. Dermatac, Prevena |
| Stryker Corporation | $103.30 | 2021-2024 | Augment Injectable |
| Abbvie INC. | $99.51 | 2022-2024 | |
| Convatec INC. | $79.54 | 2019-2025 | |
| Next Science LLC | $69.53 | 2023-2024 | Xperience, Blastx, Surgx |
| Linvatec Corporation | $67.68 | 2023 | In2bones USA, Biobrace 23mm, 5ms |
| Kerecis Limited | $63.23 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Treace Medical Concepts, INC. | $59.15 | 2023 | |
| Wright Medical Technology, INC. | $39.67 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $36.81 | 2024-2025 | Exparel, Zilretta, Iovera |
| Vertex Pharmaceuticals Incorporated | $36.48 | 2024-2025 | |
| Checkpoint Surgical, INC | $32.76 | 2023 | Checkpoint Stimulators |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $32.50 | 2023 | Nuzyra |
| Grt US Holding, INC. | $29.08 | 2021-2022 | |
| Polynovo North America LLC | $28.29 | 2024 | Novosorb Btm |
| Averitas Pharma INC. | $27.68 | 2024 | Qutenza |
| Bioventus LLC | $26.55 | 2025 | Exogen Ultrasound Bone Healing System |
| Nevro Corp. | $23.79 | 2023 | Senza |
| Eagle Pharmaceuticals, INC. | $19.84 | 2023 | |
| Aroa Biosurgery Incorporated | $19.48 | 2020 | |
| Blue Surgical LLC | $19.47 | 2025 | |
| Csl Behring | $19.42 | 2022 | |
| Axogen | $17.20 | 2019 | |
| 3m Company | $15.39 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $15.28 | 2023 | |
| Amgen INC. | $15.25 | 2022 | |
| Melinta Therapeutics, LLC | $13.64 | 2019 | |
| Allergan, INC. | $12.68 | 2019 | |
| Orthofix Medical, INC. | $12.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariano Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.